Erin currently serves as a Program Officer and Clinical Trials Specialist at the National Heart, Lung, and Blood Institute.
She received her Bachelors of Science (BS) degree from the George Washington University School of Medicine and her Masters of Science in Nursing (MSN) from the George Washington University School of Nursing.
She received a Director Team Award for developing infrastructure for conducting Phase I and II trials at NCI and for the development of the Serious Adverse Events Tracking and Reporting System at NIDA.
She has an interest in technology for home use in the aging population and was invited to serve on the White House Office of Science and Technology Policy Task Force on Research and Development for Technology to Support Aging Adults. She led an RFA called “Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point-of-Care” was an invited speaker at the American Heart Association Scientific Session 2015, “Beyond COI: Academic/Industry Partnership in the Future of Health Technology,” Orlando, FL, November 9, 2015 and served as a session moderator on “Condition Management with Mobile and Connected Health” at the mHealth Summit Annual Meeting held in Washington, DC area December 8-11, 2014. She also served as a session chair and speaker at the Drug Information Association’s Annual Meeting on “What’s the Point? Can Point of Care Technology Really Enhance Clinical Trials?” held in Boston on June 23-27, 2013.
Erin recently led a workshop on Cardiovascular Diseases in the Inmate and Released Prison Population and continues to lead efforts looking at health disparities for the inmate and released populations. She has a strong background in clinical research, including clinical trials management, education, and regulatory responsibilities.